Dr. Hadi Goubran Messiha

Professor

Build a Statement of Purpose

Generate a tailored SOP for Dr. Hadi Goubran Messiha. Improve your application with a focused, well-structured draft.

Biography

Hadi Goubran-Messiha is a distinguished Professor of Hematology Oncology at the College of Medicine, University of Saskatchewan. He obtained his MBBCh (MD), MSc, and PhD from Cairo University, Egypt, where he trained as a hematologist, later moving to Canada in 2010. He has been appointed as a regional advisor for the Royal College of Physicians of Edinburgh in Eastern Canada. Professor Goubran-Messiha has a robust research focus, publishing 56 peer-reviewed articles and book chapters with over 2500 citations in five years. He has significantly contributed to the field through his roles such as Co-Editor for “Precision Anticoagulation Medicine: Practical Guide” and “Paraproteinemia Related Disorders.” His clinical interests extend to rare blood diseases and platelet disorders.

Research Interests

Experience

Professor

2010-01-01 — Present

University of Saskatchewan • Saskatoon, Saskatchewan

Joined the Saskatoon Cancer Centre as a hematologist and appointed regional adviser for the Royal College of Physicians of Edinburgh.

Requirements for University of Saskatchewan

Master Program
Requirements
GPA Requirement
Required:3
IELTS
Listening
Required:6
Reading
Required:6
Writing
Required:6
Speaking
Required:6
Overall
Required:6.5
TOEFL
Listening
Required:19
Reading
Required:19
Writing
Required:19
Speaking
Required:19
Total
Required:86
Duolingo
Overall Score
Required:120
Overall
Required:120
Prerequisites
Four-year undergraduate degree in a relevant discipline
Application Checklist
  • Official transcripts
  • Letters of recommendation
  • Statement of intent
  • CV/Resume
Specialization Notes

Standard university-wide graduate requirements apply to most arts and science departments unless otherwise specified by the program.

Empowering the academic world by connecting researchers, professors, and students through global opportunities.

Follow Us

© 2026 ScholarLink Inc. All rights reserved.

Privacy PolicyTerms of Service